<http://webisa.webdatacommons.org/376661929>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/376661929>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<organic-reaction.com> .
<http://webisa.webdatacommons.org/376661929>	<http://www.w3.org/ns/prov#value>	"compounds of formula I and to use of the compounds in the treatment of diseases associated with LRRK2, such as neurodegenerative diseases including Parkinson's disease or Alzheimer's disease, cancer," .
<http://webisa.webdatacommons.org/prov/436841071>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/376661929> .
<http://webisa.webdatacommons.org/prov/445525850>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/376661929> .